Fidelity of Plasmodium falciparum apicoplast DNA polymerase by Parrott, Eric Evan
Graduate Theses and Dissertations Iowa State University Capstones, Theses andDissertations
2013
Fidelity of Plasmodium falciparum apicoplast DNA
polymerase
Eric Evan Parrott
Iowa State University
Follow this and additional works at: https://lib.dr.iastate.edu/etd
Part of the Biochemistry Commons
This Thesis is brought to you for free and open access by the Iowa State University Capstones, Theses and Dissertations at Iowa State University Digital
Repository. It has been accepted for inclusion in Graduate Theses and Dissertations by an authorized administrator of Iowa State University Digital
Repository. For more information, please contact digirep@iastate.edu.
Recommended Citation
Parrott, Eric Evan, "Fidelity of Plasmodium falciparum apicoplast DNA polymerase" (2013). Graduate Theses and Dissertations. 13298.
https://lib.dr.iastate.edu/etd/13298
 
 
 
Fidelity of Plasmodium falciparum apicoplast DNA polymerase 
by 
Eric Evan Parrott 
 
 
A thesis submitted to the graduate faculty  
in partial fulfillment of the requirements for the degree of 
MASTER OF SCIENCE 
 
 
Major: Biochemistry 
Program of Study Committee: 
Scott W. Nelson, Major Professor 
Richard Honzatko 
Steven M. Lonergan 
 
 
 
Iowa State University 
Ames, Iowa 
2013 
 
ii 
TABLE OF CONTENTS 
 
 
ABSTRACT 
A 
iii 
  
CHAPTER I:  INTRODUCTION 1 
 General Introduction 1 
 Thesis Outline 5 
 References 
 
6 
  
CHAPTER II:  PRE-STEADY STATE KINETICS AND FIDELITY OF PLASMODIUM 
FALCIPARUM APICOPLAST DNA POLYMERASE  
 
8 
 Abstract 8 
 Introduction 9 
 Materials and Methods 12 
 Results and Discussion 17 
 Acknowledgments 26 
 References 26 
 Tables  30 
 Figures 34 
 Supplemental Information 41 
  
CHAPTER III:  CONCLUSIONS 45 
 Summary 45 
 Future Direction 46 
 References 48 
   
ACKNOWLEDGEMENTS  49 
 
 
 
iii 
ABSTRACT 
 
Members of the phylum Apicomplexa, including pathogens such as Plasmodium 
falciparum, Toxoplasma gondii, and Babesia bovis contain a non-photosynthetic plastid called an 
apicoplast.  It has been implicated in the biosynthesis of fatty acids, iron-sulfur clusters, heme 
groups, and isoprenoid synthesis for the pathogen.  This unique plastid was immediately 
recognized as a potential target for drug discovery as it is essential for the survival and 
reproduction of the parasite.  With this in mind, our group has initiated characterization of the 
DNA replication system within the apicoplast.  Here we report our efforts to determine the 
fidelity of the DNA polymerase (apPOL) using pre-steady state kinetics.  The apPOL exhibits 
error rates typical of a high fidelity family A polymerase in the 10
4
 to the 10
6
 range and has an 
average processivity of approximately 2 nucleotides incorporated per binding event.  The data 
indicates that the rate of chemistry or a conformational change preceding the chemical step is the 
rate limiting step for sequential polymerization as inclusion of a translocation step was not 
necessary to explain the product time courses.  Additionally, with some mismatches, stalling of 
the primer extension reactions was observed, indicating that like the misincorporation reaction, 
the degree of mismatch extension is highly variable.  This stalling may indicate that  severe 
distortions of the active site following misincorporation significantly slows mismatch extension, 
which could increase the excision of the mismatch by the 3’-5’ exonuclease activity of the wild-
type apPOL and increase overall fidelity.  Finally, it was observed that the apPOL
 
will catalyze 
non-template nucleotide additions to the primer strand with a preference for dGTP, followed by 
dATP, dCTP, and dTTP. 
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CHAPTER I:  INTRODUCTION 
 
General Introduction 
Despite the advances of modern medicine in treating and preventing infectious disease, 
many diseases including malaria remain a serious threat, particularly to those living in the “third 
world.”    The World Health Organization estimates that in 2010 approximately 219 million 
people contracted malaria with approximately 660 thousand cases resulting in death (World 
Health Organization, 2013).  By far the most vulnerable people are under 5 years old, pregnant, 
or suffering from human immunodeficiency virus (HIV).  While there are currently effective 
anti-malarial drug treatments, e.g. Artemisinin-combination therapies (Dondorp et al., 2009), the 
history of malaria drugs indicates that resistance develops in as little as ten years after the drug 
becomes widely used.  For example, resistance for the drugs cholorquine, sulfadoxine-
pyrimethamine, mefloquine, and artemisinin  have all developed with the last being the current 
drug of choice (Shetty, 2012).  Artemisinin resistance was documented nine years after is wide 
spread use began  (Dondorp et al., 2009).  For this reason current drugs are often given in 
combination to reduce the likelihood of resistance to a single drug occurring (Shetty, 2012).  
While many other approaches are being taken to eliminate malaria,  including nets, insecticides, 
vaccines, etc., new drugs must be developed to combat current and future resistant strains (World 
Health Organization, 2013) (Miller et al., 2013).  
As a result of this critical need for novel treatments, many aspects of malarial disease are 
being explored with a particular interest in the causative agents of malaria, protozoa of the genus 
Plasmodium.    Malaria and diseases like it are spread through infected mosquitoes.  Five species 
of Plasmodium are responsible for human malaria including Plasmodium malariae, Plasmodium 
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vivax, Plasmodium ovale, Plasmodium knowlesi, and Plasmodium falciparum.  P. falciparum in 
the most widespread and dangerous of the malaria causing species and is the source for much of 
the drug resistance as well as 91% of the reported malaria cases (Kalanon and McFadden, 2010).  
The pathogen’s life cycle is dependent on the alternation between mosquito and 
host.  Plasmodium is part of a larger group of protozoa called the Apicomplexans.  
Apicomplexans are obligate intracellular parasites responsible for several important animal and 
human disease worldwide including Toxoplasma gondii (cats and humans), Cryptosporidium 
(humans), Theileria (cattle), and Bebesia (cattle) (Kalanon and McFadden, 2010).   
Particular to the Apicomplexans is the presence of a small 3 or 4 membraned organelle 
called the apicoplast.  Current evolutionary thought posits that the apicoplast is derived from a 
secondary endosymbiosis of a photosynthetic red algae by a eukaryotic protozoan, followed by 
the loss of photosynthetic elements and transfer of apicoplast genes to the nucleus(Lim and 
McFadden, 2010).  Recent research has revealed the apicoplast is essential and involved in the 
biosynthesis of fatty acids, iron-sulfur clusters, heme groups, and isoprenoid units.   Yeh and 
DeRisi recently showed that the Plasmodium parasite will not survive without the apicoplast but 
can be rescued by supplementation of the isoprenoid pathway products.  Interestingly, the 
parasite will survive until upon division its progeny fail to remain viable displaying a now 
characteristic “delayed death” syndrome. With its biologically unique and essential role in the 
pathogen, the apicoplast has been identified as an attractive potential drug target for the 
treatment of malaria (Yeh and DeRisi, 2011).   
Of interest to our group is the maintenance and replication of the apicoplast genome.  The 
small 35 kb apicoplast genome is circular in nature and is thought to be replicated by two 
different methods.  For the first, replication is initiated at a large inverted repeat and single 
3 
stranded unidirectional replication begins with the formation of the twin D-loops.  Secondly, 
replication has been shown to proceed in a rolling circle mechanism initiated in as yet unknown 
location. Similar processes are used by chloroplasts in plants and algae (Williamson et al., 2002).  
The number and function of proteins involved in the replisome varies from organism to 
organism. One of the simplest systems, T7 phage, uses  4 core enzymes including a polymerase 
(polymerization of deoxyribonucleotide monomers), helicase (unwinding and separation of 
duplex DNA into single strands), primase (synthesis of short RNA primers for initiation of 
lagging strand DNA synthesis), and a single-stranded binding protein (prevents premature 
annealing and protection of single stranded DNA from other enzymes).  In addition, the T7 
phage systems use the host thioredoxin as a processivity factor to greatly increase the 
processivity of the polymerase (Benkovic et al., 2001).   
The apicoplast encodes 68 genes including rRNAs, tRNAs and other housekeeping 
proteins, with the rest of the approximately 550 apicoplast proteins being encoded within the 
nuclear genome.  Nuclear encoded proteins are targeted to the apicoplast through N-terminal 
signal peptide followed by a transit peptide which is thought to be involved in targeting the gene 
product to the apicoplast and through the membranes (Waller et al., 1998).  Many putative 
apicoplast-targeted replisome enzymes have been identified including the polyprotein Pfprex 
(containing predicted polymerase, helicase, and primase activities), a topoisomerase II enzyme 
(necessary for relieving tension in the DNA coil for circular genomes), and a single-stranded 
binding protein.  No processivity factor for the apicoplast DNA polymerase has been discovered 
as yet (Lindner et al., 2011; Prusty et al., 2010; Seow et al., 2005; Weissig et al., 1997). 
  Previous research has shown that inhibition of the apicoplast-targeted topoisomerase II 
with ciprofloxacin showed anti-malarial activity (Weissig et al., 1997).  In recent years, work by 
4 
Seow, et al. identified and began characterization of the apicoplast-targeted polyprotein: Pfprex.  
Evidence suggests that the polyprotein is translated in the cytoplasm of the parasite and then 
shuttled to the apicoplast where the apicoplast DNA polymerase (apPOL) is cleaved from the 
DNA helicase and DNA primase (Seow et al., 2005).  Given its central role in DNA replication, 
the apPOL represents an attractive target for anti-malarial drug development.  In addition, other 
polymerases are currently being successfully targeted for treatment of diseases such as HIV, 
hepatitis B, and herpes simplex virus.  Research has shown that several different strategies are 
possible for inhibition of polymerase activity including DNA damaging agents, modulation of 
DNA enzymes (such as topoisomerase II), inhibiting substrate metabolism, and finally substrate 
analogs or small molecules (Berdis, 2008).  Of interest to us is the last strategy and an 
understanding of the enzymatic activity of apPOL is necessary to inform the development of 
inhibitors.  In addition, the apPOL is part of the PolA family polymerases, and particular to a 
group of PolA polymerases which are found only in the bacterial phylum Aquificae, some 
thermophilic viruses, and the Apicomplexans (Schoenfeld et al., 2013).  The nearest homolog 
outside the Apicomplexans to the apPOL is in the from the cyanobacteria Cyanothece sp. PCC 
8802 with 35% identity.  The closest human polymerases are lesion bypass polymerases theta 
and nu (23 and 22% respectively).  Within the malaria causing parasites the P. vivax apicoplast 
targeted polymerases has 84% identity, suggesting that P. falciparum apPOL drugs may be 
affective against other malaria pathogens (Wingert et al., 2013).   
Our focus with this investigation to characterize the nucleotide incorporation kinetics that 
govern replication by the apPOL.  Specifically, our aim is to use pre-steady state kinetics to 
elucidate the fidelity of the polymerase in regards to replication-induced mutations (i.e., how 
faithfully the polymerase inserts the correct nucleotide opposite the template base and the effects 
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of the incorrect base being inserted).  Although some work has been done in this area already, in 
light of our bioinformatic analysis of the Pfprex gene product, and subsequent addition of 38 
amino acids to the N-terminus of the apPOL from the previously published construct, further 
investigation is warranted.  Our group has shown a 750-fold increase in steady state activity over 
previously published results and fidelity measurements that are more in line with a replicative 
DNA polymerase, which was in some doubt in previous publications (Kennedy et al., 2011; 
Wingert et al., 2013).  The lack of a complete understanding of the kinetic mechanism and 
fidelity, combined with its importance in human health makes this an ideal system to study.  The 
desire to gain and deeper understanding of the biochemical characteristics of the apicoplast 
targeted polymerase serves as the basis for this thesis project.   
 
Thesis Outline 
For my thesis project I examined the apicoplast-targeted polymerase of Plasmodium 
falciparum (apPOL), which is thought to replicate the apicoplast genome.  I performed initial 
characterization assays and pre-steady state experiments to elucidate the kinetics that influence 
fidelity of the polymerase.   The properties of this polymerase have proven to be quite interesting 
with some surprising findings.   
This thesis is setup to highlight the progress of my research project and contains a 
manuscript in preparation that will be submitted for publication to the journal, Biochemistry.  
Chapter II contains the manuscript which discusses the initial biochemical characterization of 
apPOL, burst kinetics, pre-steady kinetics analysis and fidelity measurements, multiple turnover 
mechanisms, and analysis of the mismatch stalling.  Chapter III will be a general conclusion 
6 
discussing the accomplishments of my research project, future directions, and 
acknowledgements. 
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Abstract 
Plasmodium falciparum, the most virulent of several species that cause malaria, is a part 
of the phylum Apicomplexa whose members contain a non-photosynthetic plastid called an 
apicoplast.  This unique plastid was immediately recognized as a potential target for drug 
discovery as it is essential for the survival and reproduction of the parasite.  With this in mind, 
our group has initiated characterization of the DNA replication system within the apicoplast.  
Here we report our efforts to determine the fidelity of the DNA polymerase (apPOL) using pre-
steady state kinetics.  We find that there is a 500 to 8000-fold decrease in kpol for incorrect 
incorporation compared to correct.   We similarly find that Kd,app values are inflated, but not to 
the same degree, with increases ranging from 1.1 to 46-fold  for incorrect versus correct 
incorporation.  The apPOL exhibits error rates typical of a high fidelity family A polymerase in 
the 10
4
 to the 10
6
 range.  Additionally, with some mismatches we observed stalling of the primer 
extension reactions, indicating that like the misincorporation reaction, the degree of mismatch 
extension is highly variable.   Finally, it was observed that the apPOL
 
 will catalyze non-template 
nucleotide additions to the primer strand with a preference for dGTP, followed by dATP, dCTP, 
and dTTP.   
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Introduction 
Plasmodium falciparum, responsible for causing 91% of the reported 219 million malaria 
cases in 2010, contains a non-photosynthetic plastid called an apicoplast (World Health 
Organization, 2013).  Organisms containing an apicoplast are part of the phylum Apicomplexa.  
Many of its members are obligate intracellular parasites responsible for several animal and 
human diseases worldwide including Toxoplasma gondii and Cryptosporidium which cause 
human disease and Theileria, and Babesia, which cause economically important diseases in 
poultry and cattle (Kalanon and McFadden, 2010).  Research has revealed the apicoplast is 
essential for pathogen growth and survival.  It has been recognized to be involved in the 
biosynthesis of fatty acids, iron-sulfur clusters, heme groups, and isoprenoid synthesis.  The 
pathogen will not survive following drug induced knockout of the apicoplast but can be rescued 
by supplementation of the isoprenoid pathway products.  For that reason the apicoplast has been 
considered a potential Achilles heel for malaria (Yeh and DeRisi, 2011).   
The small 35 kb apicoplast genome is circular in nature and thought to be replicated 
through D-loop unidirectional replication and rolling circle replication similar to chloroplasts 
(Williamson et al., 2002).  Essential to the maintenance and replication of the apicoplast, the 
enzymes of the apicoplast replisome are possible drug targets (Seow et al., 2005).  68 genes 
including rRNAs, tRNAs and other housekeeping proteins are encoded with in the apicoplast, 
with the rest of the approximately 595 other apicoplast required proteins being encoded within 
the nuclear genome (Waller et al., 1998).  Many putative apicoplast targeted replication enzymes 
have been found including a polyprotein Pfprex (containing polymerase, helicase, and primase 
activities), a topoisomerase II enzyme (necessary for relieving tension in the DNA coil for 
circular genomes), and a single-stranded binding protein (Lindner et al., 2011; Prusty et al., 
10 
2010; Seow et al., 2005; Weissig et al., 1997).  Anti-malarial activity has been shown through 
inhibition of topoisomerase II with ciprofloxacin, validating the replisome has as a potential drug 
target (Weissig et al., 1997).  
The apicoplast targeted polymerase (apPOL) is thought to be cleaved upon transport from 
the cytoplasm to the apicoplast from the DNA helicase and primase domains of Pfprex (Seow et 
al., 2005).  The apPOL is part of the PolA family polymerases, and particular to a group of PolA 
polymerases which are found only in the bacterial phylum Aquificae, some thermophilic viruses, 
and the Apicomplexans (Schoenfeld et al., 2013).  The nearest homolog outside the 
Apicomplexans to the apPOL is in the from the cyanobacteria Cyanothece sp. PCC 8802 with 
35% identity.  The closest human polymerases are lesion bypass polymerases theta and nu (23 
and 22% respectively).  Within the malaria causing Plasmodium spp., the Plasmodium vivax 
apicoplast targeted polymerases has 84% identity suggesting that P. falciparum apPOL drugs 
may be affective against other malarial pathogens (Wingert et al., 2013).  Given its central role in 
DNA replication, the apPOL represents an attractive target for anti-malarial drug development.  
In addition, other polymerases are currently being successfully targeted for treatment of diseases 
such as HIV, hepatitis B, and herpes simplex virus (Berdis, 2008).  
Faithful and rapid reproduction of DNA during DNA replication or repair has long been 
recognized as the key component of the maintenance of the information encoded by the genome.  
The frequency of mutations is an important causal element for genetically influenced diseases 
such as cancer (Kunkel, 2004).  Three mechanisms govern the mutation frequency during 
replication including, DNA polymerase fidelity (the likelihood of the incorrect rather than the 
correct nucleotide incorporation), proofreading through 3’to 5’exonuclease activity (including 
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the rate of mismatch extension) and post-replication mismatch repair mechanisms (Echols and 
Goodman, 1991).   
Previous work by our group has explored fidelity measurements through steady state 
kinetics as well as mismatch extension and exonuclease activity of the apPOL (Wingert et al., 
2013).  In this investigation we will explore fidelity measurements through rapid quench single 
turnover experiments, which are thought to be the most rigorous technique for quantification of 
the kinetics of nucleotide incorporation (Johnson, 2010).   One method for the measurement of 
fidelity adapted for pre-steady state experiments by Johnson compares the frequency of 
incorporation of the incorrect nucleotide to the frequency of the incorporation of the correct 
nucleotide.  Such that the frequency of incorporation is defined as 
(kpol/Kd,app)incorrect/(kpol/Kd,app)correct, where kpol equals maximum rate of incorporation and Kd,app is 
an approximate measure of the Km.  In this way the frequency of correct and incorrect 
incorporation is measured as a function of nucleotide concentration, and a rectangular hyperbola 
fit of the single turnover experimental data to find the kobs (single-turnover rate constant) in order 
to evaluate kpol and Kd,app (Bertram et al., 2010; Johnson, 2010).   
Although some work by Kennedy et al. has been done in this area already, in light of our 
bioinformatic analysis of the Pfprex gene, and subsequent addition of 38 amino acids to the N-
terminus of the apPOL from the previously published construct, further investigation is 
warranted.  Our group has shown a 750-fold increase in steady state activity for our construct 
over previously published results from an apPOL fragment and fidelity measurements more in 
line with a replicative DNA polymerase (Wingert et al., 2013).   
The fidelity of the apicoplast was estimated to be (5.5 ± 2.9) x 10
-6
 for a β-lactamase 
reversion frequency for the apPOL and (2.3 ± 1.0) x 10
-4
 for the exonuclease negative 
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polymerase (apPOL
exo-
).  Error rates for apPOL
exo-
 of 3.9 x 10
-5
 were calculated for single-base 
substitution using the M13mp2 LacZα forward mutation assay.  In addition, steady state values 
for fidelity of the form (kcat/Km)incorrect/(kcat/Km)correct were reported, but under unusual conditions 
such that the DNA substrate concentration was very low and the polymerase concentration 
exceeded by the substrate concentration by two-fold (suggesting something more similar to  pre-
steady state conditions) (Kennedy et al., 2011).  It is our hypothesis that the sole known 
apicoplast polymerase is in fact a high fidelity polymerase typical of other A family high fidelity 
polymerases. Due to the 750-fold steady state increase in activity for our apPOL construct and 
the published concerns of steady state fidelity measurements, we here report the pre-steady state 
fidelity measurements of 12 of the possible 16 nucleotide insertions by our apPOL
exo-
 construct 
(four incorrect nucleotide incorporations are too slow for accurate quantitation) (Johnson, 2010; 
Tsai and Johnson, 2006).  We also explore the role of stalling of the apPOL following the 
incorporation of an incorrect nucleotide and an unusual terminal transferase activity by the 
apPOL.   
 
Material and Methods 
Materials– Oligodeoxynucleotides (Table 1) used for mutagenesis were purchased from 
either Integrated DNA Technologies or the Iowa State University DNA Facility. DNA 
sequencing was performed at the Iowa State University DNA Facility.  Nickel-agarose was 
purchased from Sigma-Aldrich Chemical Company.  Deoxyribonucleotides were purchased from 
Invitrogen.   
Cloning of the P. falciparum apicoplast DNA polymerase and creation of the exonuclease 
negative mutant– The open reading frame containing the apicoplast DNA polymerase encodes 
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for a poly-protein made up a DNA primase, helicase, and polymerase (Seow et al., 2005).  A 
linker region between the primase and helicase is proteolytically cleaved and it is assumed that 
the protein is cleaved between the helicase and polymerase as well (Lindner et al., 2011).  Based 
on protein sequence alignments of POM1 from the Plasmodia genus, we identified a likely 
boundary for the polymerase protein spanning amino residues 1470 through 2016.  This protein 
sequence was then converted to DNA sequence using optimal E. coli codons and synthesized 
(Genescript).  The synthesized gene was sub-cloned from the puc18 vector into the pet28b 
expression vector using the NdeI and BamHI restriction sites.  The Quickchange method of 
mutagenesis was employed to produce the exonuclease negative mutant (apPOL
exo-
).  The 
sequence of the forward primer used for mutagenesis is as follows: 5’-
gatattaaatattgcggcctgaatatccaaaccacgggtctggaagtg-3’ with the mutagenic codons for positions 
1552 and 1554 are shown in bold.  The reverse primer was the reverse complement of the 
forward.         
Protein Expression, and Purification– The purification protocol for the wild-type 
(apPOL) and exonuclease deficient (apPOL
exo-
) polymerases were identical.  Either the pet28-
apPOL or pet28-apPOL
exo-
  vectors were transformed into BL21(DE3) E. coli cells and a single 
colony was used to inoculate 100-ml flasks of LB-kanamycin that were shaken for 16 h at 37 °C.  
10 ml of starter culture was used to inoculate two 1-liter flasks of LB-kanamycin per protein, 
which were shaken at 225 rpm at 37 °C to an A600 of 0.8.  The flasks were then cooled to 18 °C, 
and expression was induced by the addition of 0.2 mM (final) isopropyl 1-thio-β-d-
galactopyranoside.  After 16 h the cells were collected by centrifugation at 4000 × g for 20 min, 
and pellets were frozen at −20 °C. 
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Target protein purification relied on a hexahistidine tag provided by the pet28 vector.  
Cell pellets containing expressed apPOL or apPOL
exo- 
(2 liters) were resuspended in 100 ml of 
Loading Buffer (20 mM Tris-HCl, 500 mM NaCl, 5 mM imidazole, 20% glycerol at pH 8.0 
[4°C]) and stored frozen at -20°C.  Following thawing, Lysis was accomplished by passage thru 
an EmulsiFlex-C5 (Avestin, Inc.) at ~16 kpsi.  The lysate was clarified by centrifugation at 
~32,500 x g and the supernatant loaded onto ~ 3 mL of Ni-Agarose resin.  The column was 
washed with 100 mL of Loading Buffer, followed by 100 mL of High Salt Buffer (5 mM 
imidazole, 1 M NaCl, 20 mM Tris-HCl, 20% glycerol at pH 8.0 [4°C]) and then 30 mL (10 
column volumes) of Ni Wash Buffer (20 mM Tris-HCl, 500 mM NaCl, 20 mM imidazole, 20% 
glycerol at pH 8.0 [4°C]).  The protein was eluted with Elution Buffer (20 mM TRIS-Cl, 200 
mM NaCl, 150 mM imidazole, 20% glycerol at pH 8.0 [4°C]).  The fractions containing protein 
were pooled and loaded onto 320 mL HiLoad™ 26/60 Superdex™ 200 prep grade column 
equilibrated with 20 mM TRIS-Cl, 400 mM NaCl,  20% glycerol at pH 8.0 (4°C).  The column 
was washed with 400 mL of 20 mM TRIS-Cl, 400 mM NaCl,  20% glycerol at pH 8.0 (4°C).   
The fractions containing protein were pooled and the concentration determined 
spectrophotometrically using an extinction coefficient (λ280 nm  = 56,750 M-1cm-1) calculated 
from the deduced protein composition. 
Burst Kinetics Experiment- The DNA template was created by annealing by annealing a 
5’-Hex labeled 20-nucleotide primer (P1) (Table 1) to a 26-nucleotide fragment (T5) (Table 1).  
Reactions were performed at pH 7.9 and 25
o
C in 50 mM potassium acetate, 20 mM Tris-acetate, 
10  mM magnesium acetate, 1 mM dithiothreitiol, and 0.1 mg/ml bovine serum albumin. The 
polymerase was diluted to 20 mM Tris-HCl, 50 mM potassium acetate, and 0.1 mg/ml BSA 
(standard buffer) prior to addition to the reaction.  The polymerase and DNA were preincubated 
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without magnesium and the reaction started with 100 μM dATP and 20 mM magnesium.  The 
assay was performed with 2 μM DNA substrate, 1 μM apPOLexo- , at 100 μM dATP with a 
timescale of 5-2100 milliseconds.  The experiment was performed on a Biologic QFM-400 
instrument.   Reaction products were resolved with 16% 19:1Acrylamide/Bisacrylamide 
denaturing PAGE containing 7.5 M urea in 1X Tris-Borate-EDTA (TBE) buffer.  Gels were run 
for 3.5 – 4 h at a constant power of 60 W, visualized using a Typhoon Fluorescence imager, and 
analyzed using the ImageJ software (NIH).  The data were then plotted and fitted to the 
following equation: 
    (     (      ))               Equation 1. 
where a, kobs, kss, and x represent the burst amplitude, the single exponential rate constant, the 
steady-state rate constant, and time, respectively.  The errors given for each parameter are 
standard errors to the fit. 
Pre-Steady state Polymerase Extension Kinetics– DNA templates were made by 
annealing a 5’-Hex labeled 20-nucleotide primer (P1 in Table 1) to a 26-nucleotide template (T1-
T16). Reactions were performed at pH 7.9 and 25
o
C in 50 mM potassium acetate, 20 mM Tris-
acetate, 10  mM magnesium acetate, 1 mM dithiothreitiol, and 0.1 mg/ml bovine serum albumin. 
The polymerase was diluted to 20 mM Tris-HCl, 50 mM potassium acetate, and 0.1 mg/ml BSA 
(standard buffer) prior to addition to the reaction. For correct nucleotide incorporations, pre-
steady-state assays were performed with 200 nM DNA substrate, 2 μM apPOLexo- , and varying 
amounts of the correct dNTP ranging from 0.5-1024 μM.  The polymerase and DNA were 
preincubated in standard buffer without magnesium and the reaction started with equal volume 
amount of varying concentrations of dNTPs, 20 mM magnesium, and standard buffer. 
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Pre-steady-state assays were performed with 200 nM DNA substrate, 2 μM apPOLexo- , and 
varying amounts of the incorrect dNTP ranging from 20-8000 μM to evaluate misincorporations 
reactions.  Reactions were quenched  at varying timescales (5 milliseconds to 2.1 seconds for 
correct incorporation  and 5 seconds to 4 hours for misincorporation) with  0.5 M EDTA.  
Correct incorporations experiments were performed using a Biologic QFM-400 rapid quench 
apparatus.  Misincorporations were performed by hand using by a stop-time method (pulling 
smaller volume out of master mix and quenching at each time point).  Reaction products were 
resolved with 16% 19:1Acrylamide/Bisacrylamide denaturing PAGE containing 7.5 M urea in 
1X Tris-Borate-EDTA (TBE) buffer.  Gels were run for 3.5 – 4 h at a constant power of 60 W, 
visualized using a Typhoon Fluorescence Imager, and analyzed using the ImageJ software 
(NIH). The kobs rates were fitted for each nucleotide concentration using an exponential rise to 
max equation: 
     (     (      ))                                          Equation 2. 
where a, kobs, and x represent the amplitude, single exponential rate constant, and time, 
respectively.  Each condition was repeated at least 3 times for correct and incorrect incorporation 
and repeats were fitted globally to the following equation: 
(     
    [    ]
      [    ]
)                Equation 3. 
where kpol, Kd,app, and x represent the single-exponential rate constant at saturating nucleotide, 
the dissociation constant for the polymerase-nucleotide complex, and the concentration of 
nucleotide, respectively.  The errors given for each parameter are standard errors to the fit.  
 
Mechanism of Multiple Nucleotide Incorporations–  For a more accurate determination of 
substrate and product amounts we used peak deconvolution software (MagicPlot 2.5, student 
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edition) to determine the relative amounts of the substrate (n) and products (n+1 through n+6).  
A plot profile for each lane was generated using NIH ImageJ and then MagicPlot was used to 
determine peak areas assuming a Gaussian distribution for each peak.  The relative areas for each 
peak were converted to amounts of DNA and time course was globally fitted using Dynafit 
software.  The script file can be found in the Supplemental Material.     
 
Results and Discussion 
P. falciparum apPol
exo-
Burst Kinetics- All misincorporation kinetics were performed using the 
exonuclease negative mutant of apPOL (apPOL
exo-
).  This mutant purifies in a similar manner to 
the wild-type construct to greater than 95% purity according to SDS-PAGE analysis. The use of 
an exonuclease negative mutant is standard for the field and enables the fidelity of the 
polymerase active site to be isolated without the confounding activity of the separate 
exonuclease domain contributing to the observed product profile.  To initiate these studies, a pre-
steady state kinetic analysis for the correct incorporation of dATP across template dTMP was 
performed to look for the presence of biphasic kinetics.  apPOL
exo-
 was preincubated with a 2:1 
molar excess of DNA-(P1/T5) in reaction buffer (no magnesium) and placed into syringe 1 and 
mixed an equal volume of 100 μM dATP, 20 mM magnesium, and reaction buffer from syringe 
2.  The reaction was quenched with 0.5 M EDTA at varying time points ranging from 5 to 2100 
ms at 25°C.  Each time point was analyzed by sequencing gel and visualized using a Typhoon 
Fluorescence Scanner.  Figure 1 shows the resulting time course demonstrating biphasic kinetics 
(a rapid burst followed by linear phase). The burst phase rate (kobs) was found to be 17.4 ± 2.1 s
-1
 
with a subsequent slower steady state rate (kss) of 0.0977 ± 0.003 s
-1
.  For many enzymes the rate 
limiting step for the first turnover (the burst) is chemistry or a conformational step receding 
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catalysis (Fiala and Suo, 2004; Johnson and Johnson, 2001).  Following this initial burst phase, 
DNA polymerases are can be limited by the rate of the slow dissociation of the polymerase from 
the replicated product or by the slow binding/assembly of the polymerase onto the primer-
template.    Preliminary steady-state experiments suggest that in the case of apPOLexo-, it is the 
slow assembly of the polymerase onto the primer-template that determines the steady-state rate.  
Under certain kinetic regimes the burst amplitude is equal to active enzyme, which was 
determined to be 0.0951 ± 0.0042, indicating that the apPOL
exo-
 is at least 19.02% active.  This 
represents the minimum for active protein since the rate of the reverse reaction and the dissociate 
rate of the pyrophosphate is currently unknown (Pryor and Washington, 2011).  
P. falciparum apPOl
exo -
Misincorporation Kinetics– Since apPOLexo- displays burst 
kinetics, pre-steady-state kinetics can be used to isolate the steps up to and including the 
chemical step of the polymerization reaction.  This ability to exclude events subsequent to 
catalysis (e.g., product dissociation) is the major advantage of a pre-steady state kinetic analysis 
as compared to a steady-state analysis.  In vivo substitution error rates for high fidelity 
polymerases with intrinsic exonuclease activity (proofreading) are commonly in the range of 10
-7
 
to 10
-8
.  This extreme high fidelity is governed by the selectivity of the polymerase active site 
(10
4
 to 10
6 
for correct over incorrect incorporation) and the intrinsic proof-reading activity of the 
exonuclease active site that removes 90 to 99% of the misincorporation errors (Kunkel, 2004).  
In order to isolate the polymerase active site, an exonuclease deficient construct was generated 
and used in all misincorporation experiments (apPOL
exo-
).   
To eliminate the potentially slow binding of apPOL
exo- 
 to the DNA substrate, a 10-fold 
excess of the enzyme was preincubated with the Hex-labeled primer-template DNA for several 
minutes to ensure that the enzyme-DNA complex was formed at t = 0 ms.  This is done to ensure 
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that primer extension follows single-turnover kinetics and the data indicate that the rate observed 
in these time-courses were essentially identical to the burst rate observed in the [DNA] > [POL] 
experiment .   
Figure 2 illustrates representative gel and schematic for the correct incorporation of 
T:dAMP (DNA-P1/T1) and the incorrect incorporation of G:dAMP (DNA-P1/T4).  As a point of 
clarification we will the shorthand notation for a primer/template base pair as T:dAMP (e.g., 
where dTTP is the incoming base and dAMP is the template base).  Figure 3 illustrates the 
representative data defining the calculation of (kpol) and (Kd,app) for the correct and incorrect 
incorporation of the above examples.  We have designed our DNA templates to contain a five 
nucleotide homopolymeric extension in order to observe continued polymerase turnover and to 
increase the separation between the substrate and product on the gel.  For the calculation of kobs, 
the percentage primer extended was calculated as [total product/ (total product + substrate)].  
Total product represents any extension of the primer (fluorescence of bands 21 and above).  
Substrate was measured as the fluorescence of band 20 (the unextended primer).   
For the correct incorporation (T:dAMP), values for kpol , Kd,app, and substrate specificity 
(kpol/Kd,app) are 46 ± 3 s
-1, 87 ± 17 μM, and 0.5 μM-1s-1 respectively (Figure 3C and Table 2).  For 
the incorrect incorporation (G:dAMP), values for kpol , Kd,app, and substrate specificity (kpol/Kd,app) 
of 0.0074 ± 0.0006 s
-1, 224 ± 56 μM, and 3.3 x 10-5 μM-1s-1 respectively (Figure 3D and Table 
2).  Data in Table 2 represent at least the global fit of 3 repeats for each condition.  We find there 
is a wide range among the overall rates of misincorporation with the slowest observable 
(G:dGMP) mismatch being approximately ~20 times slower than the fastest mismatch (T:dGMP) 
(Table 2).  Correct incorporation shows a much smaller range with G:dCMP correct 
incorporation being 2.3 times slower than A:dTTP correct incorporation (26 and 59 s
-1
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respectively).  In addition, there is a wide range Kd,app observed with C:dAMP being ~ 20 times 
greater than A:dAMP, which is the lowest Kd,app (1906 and 97 μM respectively) (Figure2).  
Correct incorporations showed a similar difference in Kd,app with the G:dCMP correct 
incorporation being ~16 fold lower than the T:dAMP correct incorporation (5.6 and 87.2 μM 
respectively)(Table 2).  A comparison of kpol, Kd,app, and substrate specificity is presented  
visually in Figure 4A, 4B, and 4C.   
There is a large discrepancy between the polymerase rates (kpol) for apPOL
exo-
 by 
Kennedy et al. and that we are reporting here (Table 2) (Kennedy et al., 2011; Wingert et al., 
2013).  There was virtually no difference in kcat values between correct and incorrect 
incorporation, with one condition in particular (G:dTMP), with a greater kcat than correct 
(A:dTMP) (Kennedy et al., 2011).  To the contrary, however; we have found a ~550-fold 
difference in kpol between correct and incorrect incorporations for these conditions.  Indeed for 
all misincorporations (A, G, C) across template dAMP there was greater than 5000-fold decrease 
in kpol from the correct incorporation. While the reason for the discrepancy is not clear, as was 
mentioned in the introduction, our construct has an additional 38 residues at the N-terminus. 
These residues are well conserved within the genus Plasmodia, but not found outside of it.  It is 
possible that the lack of these residues is responsible for the much less reported activity.   
The fidelity of correct nucleotide insertion can then be determined by the ratio of the 
specificity for the incorrect substrate over the specificity for the correct substrate (eq 3). 
 
         
(
    
     
)
         
(
    
     
)
       
                         Equation 4          
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Polymerase selectivity of correct over incorrect measured by the fidelity is a useful parameter for 
exploring the base substitution error spectrum of the apPOl
exo- 
(Boosalis et al., 1987; Johnson, 
2010).  Fidelity data are presented in Table 2 and visually illustrated in Figure 4D.  The fidelity 
value for a correct incorporation is defined as unity.  Misincorporation frequency (fidelity) 
ranged from 2.4 x 10
-4
 for G:dTMP mismatch to 9.0 x 10
-6
 for the C:dAMP mismatch.  This 
represents a 26.7 fold specificity preference for dGMP across dTMP as opposed to dCTP across 
dAMP.  We find no clear trends in the misincorporation data, other than pyrimidine-pyrimidine 
misincorporations seem to be strongly disfavored.  The rate of polymerization was found to be 
very slow for pyrimidine-pyrimidine, (on the order of hours to see any primer extension) to the 
point of being too difficult to quantify and analyze in a rigorous manner.  We have estimated a 
minimum for the fidelity of 3 of the 4 pyrimidine-pyrimidine mismatches (C:dTMP, T:dCMP, 
and C:dCMP) by estimating a kpol based on the maximum kobs for those experiments and a lower 
bound for the Kd,app as 100 μM.  These values represent a conservative estimate of the lower 
bound of Fidelity for these mismatches.  As we have selected a Kd,app of 100 μM (majority of the 
Kd,app’s are greater than this), it is assumed that the fidelities for pyrimidine-pyrimidine 
mismatches are greater than we have estimated. For the T:dTMP mismatch we discovered a 
problem with dATP nucleotide contamination that did not allow us to estimate any kinetic 
constants.  At incorrect dNTP concentrations in the low mM range, even a 0.001%  
contamination of the correct nucleotide is enough to interfere with the kinetics of this assay (e.g. 
at a concentration  of 5 mM dTTP, a 0.001% dATP contamination provides enough correct 
nucleotide to extend 25%  of the DNA substrate).  With that in mind we were careful to monitor 
our data for possible correct incorporation bursts at the beginning of our time courses. Similar 
precautions against contamination have been noted by others but could not be carried out by 
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Kennedy et al. due to the use of single-time points and a very low DNA concentration (Boosalis 
et al., 1987; Kennedy et al., 2011). 
In Figure 5 we have compared the reported fidelity measurements of apPOL here and 
previously to that of several family-A polymerases including the Klenow fragment of 
Escherichia coli polymerase I and the human mitochondrial DNA polymerase Pol γ.  apPOLexo- 
appears to display a similar pattern of fidelity measurements between each of the 5 reported 
polymerases.  G:TMP has the lowest calculated fidelity measurements across all five 
polymerases.  Additionally, it appears that pyrimidine-pyrimidine misincorporations are strongly 
disfavored (Bertram et al., 2010; Kennedy et al., 2011; Lee and Johnson, 2006; Wingert et al., 
2013).  We have noticed, as well, that despite the large differences in the rate of polymerization 
between Kennedy et al. and the data reported here, the relative ranking of misincorporations is 
very similar save for two differences.  We found the A:dAMP mismatch to be more highly 
favored, consistent with the error spectrum of the Klenow  fragment.  Secondly, our fidelity data 
are approximately 5-20 fold less at all conditions (except for A:dAMP) than previously reported 
(Kennedy et al., 2011).  It had been speculated by Schoenfeld et al., that the high mutation 
spectrum reported in Kennedy et al., may indicate that apPOL had more of “role in diversity 
generation than accurate replication” for the pathogen as a part of method to evade host immune 
systems (Schoenfeld et al., 2013).  While that may still be the case, the error rates reported here 
(10
-4-
10
-6
) are typical of high fidelity polymerases.  Additionally, the apPOL has intrinsic 
exonuclease activity which, for other polymerases typically removes 90-99% of mismatches 
(Kunkel, 2004).  As the apPOL is the only known polymerase targeted to the apicoplast, its role 
in maintaining genetic integrity is important.  
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Mechanism of Multiple Nucleotide Incorporations– In and effort to understand better the 
mechanism for multiple successive nucleotide incorporations we fit the product amount at each 
possible product position (n+1 through n+6) as a function of time to several proposed 
mechanisms (Figure 6).  We discriminated between two possible mechanisms (Scheme 1 or 
Scheme 2) using Dynafit 3 as described in the Supplemental Material.  One mechanism included 
a translocation step (kt) and the other mechanism had only a polymerization step.  The resulting 
kinetic constants are found in Table 3 and Table 4. 
 
        
        
⇔            
    
→                Scheme 1 
 
        
        
⇔            
    
→            
      
→         Scheme 2 
 
The data fit best to Scheme 1, indicating that the rate of catalysis or a conformational 
change preceding catalysis is the rate limiting for sequential polymerization since inclusion of a 
translocation step was not necessary to explain the product time courses.  The rate of 
translocation must be at least 10-fold greater than kpol.  The fitted rate constants were as follows:  
kpol, 24.5±2.5 s
-1
; koff1, 13.47±4.23 s
-1
, kon1, 0.575±0.002 M
-1
s
-1; and [ED], 0.14 μM.  kon1 is slow 
and koff1 is fast, suggesting why the first products (n+1, n+2) do not go to zero during the time of 
the experiment.  The processivity (kpol/koff) is approximately 2, which means that for every 
successful nucleotide incorporation, there is a ~75% the next nucleotide will be incorporated as 
well.   
Stalling following mismatch and terminal transferase activity- During the course of the 
pre-steady state misincorporation experiments we observed two interesting phenomena, stalling 
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of primer extension following insertion of a mismatch and the extension of non-template single 
stranded DNA.  First, as mentioned above, we have designed our DNA templates to contain a 
five nucleotide homopolymeric extension in order to observe continued polymerase turnover.  
This is a useful construct for steady state misincorporation studies as it helps to eliminate 
problems with slow product dissociation when a processive polymerase is stalled at the n+1 
DNA product (Hacker and Alberts, 1994; Johnson, 2010).  While that is not a concern for pre-
steady state experiments because we are only interested in the first turnover from a kinetic 
standpoint, this particular DNA substrate does allow for added separation between the primer 
and primer extension products.  As the turnover for the correct incorporation (bands 22-26, 
Figure 7) is much faster than the incorrect, often the misincorporation band (band 21, Figure 6) is 
not present allowing for greater separation for measurement between primer extension and 
primer.  For three conditions (Figure 7D, 7E,7F), however; we observed stalling of primer 
extension at either the misincorporation (band 21) (A:AMP, A:GMP) or at the two subsequent 
correct incorporations (band 22 and 23) (T:GMP).  This was seen at all concentrations of dNTPs 
that were measured for these conditions.  For all other nucleotide insertions, this pattern was not 
observed.   
Work by Johnson and Beese may shine some light on to these observations.  They 
crystallized the thermophilic Bacillus DNA Polymerase I fragment with each of the possible 
mismatches and observed the effect of the mismatch on the structure of the active site.  For the 
A:dAMP mismatch they observed that bases were not paired within the active site because of 
steric clashes with residues due to rearrangement of the active typical of mismatches.  We 
observed that the A:dAMP was stalled at the n+1 position suggesting that the active site was 
distorted enough to prevent release and translocation of the mismatch.  The observable effect of 
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the mismatch disappears once the translocation does occur however.  For the A:dGMP mismatch 
the crystal structure show that the active site was severely distorted with the finger domain  
blocking the pre-insertion site for the next nucleotide.  This is a likely explanation for the stalling 
of the n+1 site for A:dGMP position as well.  Finally, we observed that for the T:dGMP 
mismatch stalling was observed at the first two correct incorporations.  Johnson and Beese 
observed distortions throughout the active site including the placement of primer and template 
strands.  It appears that contrary to the previous described stalling, the polymerase is able to 
catalyze the mismatch and move to the next incorporation.  At that point, however; it appears 
that the mismatch distorts the DNA duplex binding region enough to stall the normally very fast 
correct incorporation of dTTP into dAMP.  This is appears to be a form of “memory” for the 
mismatch that has been observed in other polymerases (Johnson and Beese, 2004).   
Severe reduction of mismatch extension because of active site distortion may be a way 
for polymerases with intrinsic exonuclease activity (or encoded by a separate gene), to increase 
the likelihood of mismatch being excised (Goodman and Fygenson, 1998; Kunkel, 2004).  It is 
possible that while two of these mismatches (A:dAMP and T:dGMP) have lower fidelities as 
measured by the our pre-steady state data (ranked 2 and 3 respectively), in vivo, the presences of 
these mutations may be more unlikely then predicted because the effect of stalling observed here 
on mismatch extension.  This could also affect the interpretation of steady state fidelity 
measurements if the rate of product dissociation becomes rate limiting as result.    More work on 
the kinetics of this finding will need to be done to understand its effect, on the overall fidelity of 
the polymerase.   
The second phenomenon we observed was non-template nucleotide additions to the 
primer strand by the apPOL
exo-
 beyond the end of the template.  This pattern was seen for all 4 
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deoxyribonucleotides at sufficiently high nucleotide concentration, though not to the same 
extent.   After 1 hour and with a dGTP concentration of 1.28 mM, a 10 base single-stranded 
overhangs can be seen (Figure 7A).  To a lesser extent, the apPOL
exo-
 will extend dATP (4 bases, 
Figure 7B), dCTP (3 bases, Figure 7C), and dTTP (1 base, Figure 7D) as well.  3’ blunt-end 
nucleotide addition has been observed in a many different polymerases from all three domains 
but to our knowledge this is the first example of multiple nucleotide additions being made by an 
A family DNA polymerase (Fiala et al., 2007).  While we are unsure if these observations have 
any physiological relevance at this time, it is intriguing to speculate that this could have a role in 
non-homologous end joining observed in polymerases involved in DNA repair (e.g. human DNA 
polymerase μ) (Andrade et al., 2009).  Of note, for most polymerases, dATP is strongly favored 
for extension in contrast to the preferential extension of dGTP found here (Obeid et al., 2010).   
The apPOL is a potential target for drug discovery, and this report provides essential data 
on the polymerase for further work.  These experiments have established the fidelity data needed 
for evaluating the effect of any nucleotide analogs or allosteric small-molecule inhibitors on 
fidelity.   
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Tables 
 
 
 
 
 
 
Table 1. 
5'-/5HEX/
3'-
b 
Primer is 5' labeled with Hexachlorofluorescein
Primer/Template
T15
T16
T5
T6
T7
T8
5'-CCCCCGCACTAGCTGACTGACACCTG-3'
5'-CCCCCCCACTAGCTGACTGACACCTG-3'
5'-AAAAACCACTAGCTGACTGACACCTG-3'
5'-TTTTTCCACTAGCTGACTGACACCTG-3'
5'-GGGGGCCACTAGCTGACTGACACCTG-3'
5'-CCCCCTCACTAGCTGACTGACACCTG-3'
5'-TTTTGGCACTAGCTGACTGACACCTG-3'
5'-AAAAAGCACTAGCTGACTGACACCTG-3'
5'-TTTTTGCACTAGCTGACTGACACCTG-3'
5'-/5HEX/CAGGTGTCAGTCAGCTAGTG-3'
5'-AAAAAACACTAGCTGACTGACACCTG-3'
5'-TTTTTACACTAGCTGACTGACACCTG-3'
5'-GGGGGACACTAGCTGACTGACACCTG-3'
5'-CCCCCACACTAGCTGACTGACACCTG-3'
5'-TTTTTTCACTAGCTGACTGACACCTG-3'
5'-AAAAATCACTAGCTGACTGACACCTG-3'
5'-GGGGGTCACTAGCTGACTGACACCTG-3'
a
example: (DNA-P1/T1) Primer/template pair for T:dAMP 
CAGGTGTCAGTCAGCTAGTG-3'
GTCCACAGTCAGTCGATCACAAAAAA-5'
 Primer/Template sequences for incorporation studies
a
T9
T10
T11
T12
T13
T14
P1
b
T1
T2
T3
T4
Name
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Table 2.
DNA dNTP/template K d,app  (μM)
a
k pol  (s
-1
)
a
k pol /K d,app    (μM
-1
·s
-1
) Fidelity
h
P1/T2 A·dAMP 96.5 ± 28.4 0.0085 ± 0.0008 8.8 x 10
-5
1.7 x 10
-4
P1/T4 G·dAMP 223.5 ± 56.4 0.0074 ± 0.0006 3.3 x 10
-5
6.3 x 10
-5
P1/T3 C·dAMP 1906.2 ± 339.3 0.009 ± 0.0008 4.7 x 10
-6
9.0 x 10
-6
P1/T1 T·dAMP 87.2 ± 16.7 45.7 ± 3.1 5.2 x 10
-1 1
P1/T12 G·dGMP 112.5 ± 37.0 0.0053 ± 0.0004 4.7 x 10
-5
3.2 x 10
-5
P1/T11 A·dGMP 1290.5 ± 180.2 0.0211 ± 0.0011 1.6 x 10
-5
1.1 x 10
-5
P1/T10 T·dGMP 586.5 ± 125.3 0.0799 ± 0.0064 1.4 x 10
-4
9.3 x 10
-5
P1/T9 C·dGMP 28.3 ± 10.8 41.4 ± 4.2 1.5 x 10
0 1
P1/T16 C·dCMP 100
b
0.001
d
1.0 x 10
-5g
2.2 x 10
-6i
P1/T15 A·dCMP 219.9 ± 55.8 0.01304 ± 0.0010 5.9 x 10
-5
1.3 x 10
-5
P1/T14 T·dCMP 100
b
0.0019
e
1.9 x 10
-5g
4.1 x 10
-6i
P1/T13 G·dCMP 5.57 ± 1.24 25.7 ± 1.5 4.6 x 10
0 1
P1/T6 T·dTMP ND
c
ND
c -- --
P1/T7 C·dTMP 100
b
0.0005
f
5 x 10
-6g
2.4 x 10
-6i
P1/T8 G·dTMP 209.9 ± 60.9 0.105 ± 0.0087 5.0 x 10
-4
2.4 x 10
-4
P1/T5 A·dTMP 27.9 ± 2.5 59.2 ± 1.5 2.1 x 10
0 1
h
 Fidelity is calculated by (k po l/K d,app )incorrect/(k pol /K d,app )correct
a
 Standard error of the data fit to the Michaelis-Menten equation
b
 K d,app  set at 100 μM (estimate)
i
 Estimated lower bound for Fidelity 
Fidelity of single-nucleotide insertion by apPol
exo-
c
 Not Detectable
d
 kpol  estimate bases on max k obs  value at 4 mM dCTP
e
 kpol  estimate bases on max k obs  value at 320 μM dTTP
f
 kpol  estimate bases on max k obs  value at 12 mM dCTP
g
 Estimated lower bound for selectivity 
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Parameter Initial Fit Error %
k pol 10 23.6
a 2.17 9.2
k off1 6 11.41
b 3 26.3
k on1 0.1 0.09725
c 0.01865 19.2
[ED] 0.15 0.13745
d 0.00237 1.7
a
 s
-1
, 
b
 s
-1
, 
c
 μM
-1
s
-1
, 
d
 μM
Table 3.  Kinetic Parameters from Global Fit of Multiple 
Nucleotide Incorporations with infinitely fast 
translocation step 
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Parameter Initial Fit Error %
k pol 10 22.43
a 2.003 8.9
k t 10 10000000
b 7.16E+09 71610
k off1 6 9.787
c 2.564 26.2
k on1 0.1 0.08804
d 0.01823 20.7
[ED] 0.15 0.13718
e 0.002444 1.8
a
 s
-1
, 
b
 s
-1
, 
c
 s
-1
, 
d
 μM
-1
s
-1
, 
e
 μM
Table 4.  Kinetic Parameters from Global Fit of Multiple 
Nucleotide Incorporations with fitted translocation step 
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Figures 
 
 
Figure 1:  Nucleotide incorporation by apPOL
exo-.  (A)  1 μM 
apPOL
exo-
 preincubated with 2 μM DNA (P1/T5) and then mixed with 
100 μM dATP for varying lengths of time (5-2100 ms).  The amount 
of primer extension was plotted as a function of time to equation 1.  
Amplitude was equal to 0.0951±0.0042, kobs was equal to 17.4±2.1 s
-1
, 
and kss was equal to 0.0977±0.0003 s
-1
.  (B) Gel image of primer 
extension 
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Figure 2.  Pre-steady state kinetics for correct and incorrect incorporation of nucleotides.   (A)  
Correct incorporation of dTTP across dAMP. The band labeled 20 is the primer-template.  Bands 
21-26 are the correct nucleotide extension of the primer template.  (B) Incorrect incorporation of 
dGTP across dAMP.  The band labeled 20 is the primer-template. Band 21 is position of the 
mismatch.  Bands 22-26 are the correct nucleotide extension of the primer template.  Bands 27-
31 are non-template single-stranded extension of dGTP. 
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Figure 3. Kinetic assays for the deducing of apPOL fidelity. (A) Single exponential fits of 
Figure 2 dTTP across A data.  ● 2 μM dATP, kobs (1.6±0.4 s
-1) ▲ 4 μM dATP, kobs (2.3±0.7 s
-1
)  
♦ 8 μM dATP, kobs (3.4±0.5 s
-1) ■ 16 μM dATP, kobs (8.2±1.5 s
-1
)  x 32 μM dATP, kobs (14.3±3.0 
s
-1) + 64 μM dATP, kobs (17.2±2.5 s
-1) ► 128 μM dATP, kobs (26.0±3.0 s
-1) ◄ 256 μM dATP, 
kobs (32.9±5.1 s
-1)  (B) Single Exponential fits of Figure 2 dGTP across A data.  ● 40 μM dGTP, 
kobs (0.0015±0.0003 s
-1) ▲ 80 μM dGTP, kobs (0.0021±0.0002 s
-1) ♦ 160 μM dGTP, kobs 
(0.0031±0.0003 s
-1) ■ 320 μM dGTP, kobs (0.0051±0.0003 s
-1
) x 640 μM dGTP, kobs 
(0.0071±0.0007 s
-1) + 1280 μM dGTP, kobs (0.0081±0.0008 s
-1
) (C) Michaelis-Menten fit of kobs 
(correct incorporation) values plotted as a function of dATP concentrations with kpol (41.6±2.6 s
-
1
) and Kd,app (74.3±11.3). (D) Michaelis-Menten fit of kobs (incorrect incorporation) values plotted 
as a function of dGTP concentrations with kpol (0.01027±0.0005 s
-1
) and Kd,app (320.0±42.1). 
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Figure 4.  Fidelity of single-nucleotide insertion by apPOL
exo-
.  (A) Variation in the maximum 
rate of polymerization, kpol (s
-1) † kpol estimate bases on max kobs value at 320 μM dTTP, ‡ kpol  
estimate bases on max kobs value at 12 mM dCTP, § kpol  estimate bases on max kobs value at 4 
mM dCTP. (B) Variation in the dissociation constant, Kd,app (μM) ¤ Kd,app set at 100 μM 
(estimate).  (C) Variation in the specificity constant, (μM-1·s-1) ₪ Estimated lower bound for 
selectivity.  (D) Variation in Fidelity, ((kpol/Kd,app)incorrect/( kpol/Kd,app)correct) ₰ Estimated lower 
bound for fidelity. 
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Figure 5.  Comparisons of fidelity among selection of family A polymerases.  (From the Left) 
Pre-steady State apPOL
exo-
 fidelity reported here.  Steady State apPOL
exo-
 fidelity reported 
(Wingert, et al. 2013), Steady state apPOL
exo-
 fidelity (Kennedy, et al. 2011), Pre-steady state 
fidelity E. Coli Pol I  (Bertram, et al. 2010), Pre-steady State H. sapiens Pol γ (Lee and 
Johnson 2006).  
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Figure 6. Multiple Nucleotide Incorporations. (о) % Primer-template, (□) % n+1 product, (up 
triangle) % n+2 product, (down triangle) % n+3 product, (diamond) % n+4 product, (right 
triangle) % n+5 product, (left triangle) % n+6 product.  
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Figure 7. Mismatch extension stalling and non-template single strand extension.  (A) dGTP non-
template single strand extension. (B) dATP non-template single strand extension (C) dCTP non-
template single strand extension (D) dTTP non-template single strand extension, n-2,n+3 stalling 
for T:dGMP mismatch (E) n+1 stalling of A:dAMP mismatch (F) n+1 stalling of A:dGMP 
mismatch 
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Supplemental Material 
Dynafit Script─ 
 
[task] 
 
task = fit 
data = progress 
model = chem ? 
 
[mechanism] 
 
A --> A : k10 
ED + NTP <==> EDNTP  : k1 k2 
EDNTP --> EDD + PP : kpol 
ED <==> E + D : koff1 kon1 
EDNTP <==> E + NTP + D : koff1 kon1 
 
EDD + NTP <==> EDDNTP  : k1 k2 
EDDNTP --> EDDD + PP : kpol 
EDD <==> E + DD : koff1 kon1 
EDDNTP <==> E + NTP + DD : koff1 kon1 
 
EDDD + NTP <==> EDDDNTP  : k1 k2 
EDDDNTP --> EDDDD + PP : kpol 
EDDD <==> E + DDD : koff1 kon1 
EDDDNTP <==> E + NTP + DDD : koff1 kon1 
 
EDDDD + NTP <==> EDDDDNTP  : k1 k2 
EDDDDNTP --> EDDDDD + PP : kpol 
EDDDD <==> E + DDDD : koff1 kon1 
EDDDDNTP <==> E + NTP + DDDD : koff1 kon1 
 
EDDDDD + NTP <==> EDDDDDNTP  : k1 k2 
EDDDDDNTP --> EDDDDDD + PP : kpol 
EDDDDD <==> E + DDDDD : koff1 kon1 
EDDDDDNTP <==> E + NTP + DDDDD : koff1 kon1 
 
EDDDDDD + NTP <==> EDDDDDDNTP  : k1 k2 
EDDDDDDNTP --> EDDDDDDD + PP : kpol 
EDDDDDD <==> E + DDDDDD : koff1 kon1 
EDDDDDDNTP <==> E + NTP + DDDDDD : koff1 kon1 
 
[constants] 
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k1 = 50 
k2 = 1 
kpol = 10? 
k10 = 1 
koff1 = 6? 
kon1 = .1? 
 
[concentrations] 
ED = .15? 
A = .3 
NTP = 200 
E = 0.25 
 
[progress] 
 
directory ./fitting/polymerase/data 
extension txt 
 
file n 
response ED = 5,EDNTP = 5, D = 5, A = 1 
 
file n1 
response EDDNTP = 5, EDD = 5,  DD = 5 
file n2 
response EDDDNTP = 5, EDDD = 5,  DDD = 5 
file n3 
response EDDDDNTP = 5, EDDDD = 5,  DDDD = 5 
file n4 
response EDDDDDNTP = 5, EDDDDD = 5,  DDDDD = 5 
file n5 
response EDDDDDDNTP = 5, EDDDDDD = 5,  DDDDDD = 5 
file n6 
response  EDDDDDDD = 5,  
 
[output] 
directory ./fitting/polymerase/output 
 
[task] 
task = fit 
data = progress 
model = trans ? 
 
[mechanism] 
 
A --> A : k10 
ED + NTP <==> EDNTP  : k1 k2 
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EDNTP --> EDD* + PP : kpol 
EDD* ---> EDD : kt 
ED <==> E + D : koff1 kon1 
EDNTP <==> E + NTP + D : koff1 kon1 
 
EDD + NTP <==> EDDNTP  : k1 k2 
EDDNTP --> EDDD* + PP : kpol 
EDDD* ---> EDDD : kt 
EDD <==> E + DD : koff1 kon1 
EDDNTP <==> E + NTP + DD : koff1 kon1 
 
EDDD + NTP <==> EDDDNTP  : k1 k2 
EDDDNTP --> EDDDD* + PP : kpol 
EDDDD* ---> EDDDD : kt 
EDDD <==> E + DDD : koff1 kon1 
EDDDNTP <==> E + NTP + DDD : koff1 kon1 
 
EDDDD + NTP <==> EDDDDNTP  : k1 k2 
EDDDDNTP --> EDDDDD* + PP : kpol 
EDDDDD* ---> EDDDDD : kt 
EDDDD <==> E + DDDD : koff1 kon1 
EDDDDNTP <==> E + NTP + DDDD : koff1 kon1 
 
EDDDDD + NTP <==> EDDDDDNTP  : k1 k2 
EDDDDDNTP --> EDDDDDD* + PP : kpol 
EDDDDDD* ---> EDDDDDD : kt 
EDDDDD <==> E + DDDDD : koff1 kon1 
EDDDDDNTP <==> E + NTP + DDDDD : koff1 kon1 
 
EDDDDDD + NTP <==> EDDDDDDNTP  : k1 k2 
EDDDDDDNTP --> EDDDDDDD* + PP : kpol 
EDDDDDDD* ---> EDDDDDDD : kt 
EDDDDDD <==> E + DDDDDD : koff1 kon1 
EDDDDDDNTP <==> E + NTP + DDDDDD : koff1 kon1 
 
[constants] 
 
k1 = 50 
k2 = 1 
kpol = 10? 
kt = 10? 
koff1 = 6? 
kon1 = .1? 
k10 = 1 
 
[concentrations] 
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ED = .15? 
A = .3 
NTP = 200 
E = 0.25 
 
[progress] 
directory ./fitting/polymerase/data 
extension txt 
 
file n 
response ED = 5,EDNTP = 5, D = 5, A = 1 
file n1 
response EDDNTP = 5, EDD = 5,  DD = 5, EDD* = 5 
file n2 
response EDDDNTP = 5, EDDD = 5,  DDD = 5, EDDD* = 5 
file n3 
response EDDDDNTP = 5, EDDDD = 5,  DDDD = 5, EDDDD* = 5 
file n4 
response EDDDDDNTP = 5, EDDDDD = 5,  DDDDD = 5, EDDDDD* = 5 
file n5 
response EDDDDDDNTP = 5, EDDDDDD = 5,  DDDDDD = 5, EDDDDDD* = 5 
file n6 
response  EDDDDDDD = 5, EDDDDDDD* = 5 
 
[output] 
directory ./fitting/polymerase/output 
 
[end] 
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CHAPTER III: CONCLUSIONS 
 
Summary 
 
In the course of this investigation it was our goal to accurately chart the substitution error 
map for the apPOL using pre-steady state kinetics.  Our group has previously performed steady 
state kinetics for the apPOL; however, in terms of DNA polymerase fidelity, conclusions based 
on steady state kinetics have been questioned on theoretical grounds, primarily because the  the 
slow dissociation of the DNA-polymerase complex may not reflect differences in nucleotide 
selectivity.  Therefore, one of our goals was to confirm and extend our earlier steady state 
analysis (Wingert et al., 2013) with pre-steady state fidelity measurements.  We were able to 
demonstrate the presence of a biphasic time course, confirming our pre-steady state kinetics 
represented single turnover conditions.  We found that, for the most part, each study has 
indicated that apPOL has error rates typical of high fidelity A family polymerases (Kunkel, 
2004).  Additionally, it was our goal to expand and correct the work done previously by Kennedy 
et al. with a smaller apPOL fragment (Kennedy et al., 2011).  We found that there was between a 
500- and 8000-fold decrease in kpol for incorrect incorporation compared to correct.   We 
similarly found that Kd,app values are inflated, but not to the same degree with a range of  1.1 to 
46 fold increase for incorrect versus correct incorporation.  The apPOL exhibits error in the 10
4
 
to the 10
6
 range.   The lowest calculated fidelity misincorporations were G:dTMP and A:dAMP 
and the highest fidelity that were able to observe were for A:dGMP and C:dAMP.  Even greater 
estimated fidelities were found for the pyrimidine-pyrimidine mismatches (C:dCMP, T:dTMP, 
C:dTMP, and T:dCMP), which appear to be strongly disfavored as we had difficulty accurately 
quantitating their extremely slow rates.  Other than slow pyrimidine-pyrimidine 
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misincorporations, we did not observe any obvious trends in fidelities (e.g. purine-purine 
mismatches were not favored or disfavored as compared to purine-pyrimidine).    
We also determined that the apPOL has an average processivity of approximately 2, i.e., 
for every correct incorporation there is a 75% chance that the next nucleotide will be 
incorporated.    Additionally, it appears that the rate of catalysis or a conformational change 
preceding is the rate limiting step for sequential polymerization as inclusion of a translocation 
step was not necessary to explain the product time courses.  
The analysis of our misincorporation experiments revealed a high degree of stalling in the 
primer extension reaction after the initial turnover for T:dGMP,  A:dAMP, and A:dGMP.  This 
stalling may indicate that  severe distortions of the active site following misincorporation 
significantly slows mismatch extension, which could increase the excision of the mismatch by 
the 3’-5’ exonuclease activity of the wild-type apPOL.  It was  also surprising to observe non-
template nucleotide additions to the primer strand by the apPOL
exo-
 beyond the end of the 
template with a preference for dGTP over dATP.  More work will need to be done to see if this 
has any physiological relevance.  The apPOL represents a potential target for drug discovery, and 
this report provides the essential data needed for further work on the polymerase.  The impact of 
small molecules or nucleotide analogs on polymerase fidelity for drug screening will depend on 
the accurate fidelity data presented here for comparison. 
 
Future Directions 
We plan to continue expand the scope of the experiments reported here and explore some 
of the questions that arose during the course of these experiments.  We are interested in 
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understanding the micro rate constants governing each step of nucleotide incorporation.  The 
rate-limiting step for many polymerases is either the catalytic or a conformational change 
preceding catalysis (Johnson, 2010; Tsai and Johnson, 2006).  To do this we plan to explore the 
dTTP(αS) elemental effect on the kpol rate of incorporation.  It has been shown in other 
polymerases, that the making or breaking of a phosphate bond will decrease the rate of catalysis 
(phosphothiote elemental effect).  If the rate limiting step is the rate of catalysis then this effect 
will be observed, if not it suggests that the conformational change preceding catalysis is the rate 
limiting step (Fiala and Suo, 2004; Patel et al., 1991).  We plan to determine the Kd-DNA  
through active site titration using various concentrations of DNA through a similar to a process 
described for the burst kinetics reported above.  Additionally, this would provide us with a better 
calculation of the percentage active enzyme.  We also plan to use a pulse-quench experiment to 
calculate the koff of the DNA-enzyme complex (Fiala and Suo, 2004).   
In the course of our pre-steady state experiments we noticed non-template nucleotide 
additions to the primer strand by the apPOL
exo-
 beyond the end of the template.  These additions 
were done under “running-start” conditions where the polymerase rapidly incorporated 
nucleotides across the template before beginning non-template addition.  We are interested to see 
whether or not the polymerase will catalyze addition to blunt-end DNA and single-stranded 
DNA, as it appears the apPOL extended dGTP well past the point where it would have been still 
bound to double-stranded portion of the DNA substrate.  Non-template terminal transferase 
activity is unique in A family polymerases, but has been found to have a role in non-homologous 
end joining for X-family polymerases (Andrade et al., 2009).  The physiological relevance, if 
any, of terminal transferase activity in apPOL is unclear.     
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